Form D · Other Technology
GATC HEALTH CORP
Irvine, CA · CIK 0001822995
Offering snapshot reported Sep 15, 2025 · SEC filing
- Reported sold
- $26M Offering amount: $50M
- Investors reported
- 251 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jul 14, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2025 | Amendment | $25,995,895 | No comparison | 251 | SEC filing |
| Sep 20, 2023 | Initial | $621,000 | No comparison | 22 | SEC filing |
| Aug 23, 2023 | Initial | $240,000 | No comparison | 3 | SEC filing |
| May 17, 2023 | Amendment | $10,600,000 | $600,000vs Apr 12, 2023 | 162 | SEC filing |
| Apr 12, 2023 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Apr 12, 2023 | Amendment | $10,000,000 | $9,980,000vs Dec 22, 2021 | 154 | SEC filing |
| Aug 25, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 22, 2021 | Initial | $20,000 | No comparison | 1 | SEC filing |
| Dec 22, 2021 | Amendment | $1,748,569 | $1,648,569vs Sep 14, 2021 | 57 | SEC filing |
| Sep 14, 2021 | Initial | $100,000 | No comparison | Not reported | SEC filing |
| Jun 30, 2021 | Amendment | $3,420,587 | No comparison | Not reported | SEC filing |
| Oct 6, 2020 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Sep 11, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0 (estimated)
- Finders' fees
- $7.5M (estimated)
- Form D file number
- 021-490495
Sales commissions include warrants and similar non-cash compensation. Issuer reserves the right to engage finders in compliance with SEC proposed rules.
Source: Form D, filed Sep 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Davidson | Director |
| Gerald De Ciccio | Executive |
| Rahul Gupta | Executive |
| Uri Litvak | Director |
| Dennis Locke | Director |
| Michael Manahan | Executive |
| Gerry Martin | Director |
| Jeff Moses | Director, Executive |
| John Stroh | Executive |
| Phillip Trad | Director |
| Jayson Uffens | Director, Executive |
| Lin Yu | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2030 Main Street Suite 660
Irvine, CA, 92614
Irvine, CA, 92614